Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Anti-inflammatory drugs were originated firstly by serendipitous discovery of certain plants and their extracts being applied for the relief of pain, fever and inflammation. When salicylates were discovered in the mid-19th century to be the active components of willow spp., this enabled compounds to be synthesized and from this, acetyl-salicylic acid or aspirin trademark was developed. Similarly, the chemical advances of the 19-20th centuries lead to discovery of the NSAID’s, most of the NSAID’s were organic acids initially, but later on non-acidic compounds were discovered.
The Europe anti-inflammatory therapeutics market is witnessing lucrative growth during forecast period of 2021 to 2027. The inflammation is a natural immune response of human which is chiefly activated to clear dead cells and eliminate the cause of injury. The key factors such as new drug pipelines is propelling the growth of Europe anti-inflammatory therapeutics market. Increasing adoption rate of anti-inflammatory drugs is also boosting growth of Europe anti-inflammatory therapeutics market. However, patent expiry of drugs is restraining the growth of Europe anti-inflammatory therapeutics market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the anti-inflammatory therapeutics market. In addition, complete analysis of changes on anti-inflammatory therapeutics organizations expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Europe economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth. The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics.
The Europe anti-inflammatory therapeutics market is categorised into drug class, indication, end users and country.
Based on drug class, the Europe anti-inflammatory therapeutics market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs, corticosteroids, immune-selective anti-inflammatory derivative and other. In which corticosteroids is also contributing in the growth of Europe anti-inflammatory therapeutics market. The corticosteroids are synthesized drugs which are structurally similar to the cortisol which is a hormone that is produced by adrenal gland. They are helps in preventing synthesis of chemical mediators which causes inflammation. This makes them more demandable in the market.
Based on indication, the Europe anti-inflammatory therapeutics market is segmented into arthritis, chronic obstructive pulmonary diseases, multiple sclerosis, inflammatory bowel diseases, asthma, tendonitis and other. In which asthma is also contributing in the growth of Europe anti-inflammatory therapeutics market. The asthma is a condition in which your airways narrow and swell and can cause extra mucus. It may cause difficulty in breathing, trigger coughing and whistling sound at the time of breathing along with shortness of breath. The asthma may cause dull ache or sharp, stabbing pain along with heavy brick sitting on the chest. The rising prevalence of asthma is propelling growth of Europe anti-inflammatory therapeutics market.
Based on end user, the Europe anti-inflammatory therapeutics market is categorised into hospital pharmacies, online pharmacies and retail pharmacies. The retail pharmacies is also contributing in the growth of Europe anti-inflammatory therapeutics market. The rising prevalence of chronic diseases is propelling growth of Europe anti-inflammatory therapeutics market. The new product launch is also boosting growth of Europe anti-inflammatory therapeutics market.
The Europe anti-inflammatory therapeutics market is studied for key countries such as UK, Germany, France, Italy and Spain. In which UK is anticipated to dominate the market in 2020. The rising prevalence of arthritis is propelling growth of Europe anti-inflammatory therapeutics market. The growing elderly population is boosting growth of Europe anti-inflammatory therapeutics market. The rising economy development is also driving growth of Europe anti-inflammatory therapeutics market.
The major key players operating in the market are Amgen Inc, Astrazeneca Plc., Eli Lily And Company., Hoffmann-La Roche Ag, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Ag and Pfizer Inc among others.
Jun 2020: FDA approved Novartis Ilaris which contains canakinumab for new indication to treat adult-onset still’s disease (AOSD).
March 2020: GSK’s consumer healthcare launched the biggest innovation in the U.S. as Over the counter oral pain relief category under the brand name of Advil dual action which comprised of the acetaminophen and ibuprofen.
The study comprised of the anti-inflammatory therapeutics market. In which study analysed the various segment of the market such as drug class, indication, end user and country. The study also comprised of dominating segment of the market. The drug class segments is dominated by anti-inflammatory biologics. Likewise, indication segment is dominated by arthritis, end user segment is dominated by hospital pharmacies and country segment is dominated by the United Kingdom. The study also covers the impact of COVID-19 on the anti-inflammatory therapeutics market and concludes that the COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth. The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics. The study also imparts the major key players operating in the market.
Why to buy this report
